Melanoma: the role of surgery in the era of new therapies

por Mozzillo, Nicola, Ascierto, Paolo A
Publicado 2014

Update in the treatment of non-melanoma skin cancers: the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinoma

por Ascierto, Paolo A, Schadendorf, Dirk
Publicado 2022

Adjuvant therapy of melanoma with interferon: lessons of the past decade

por Ascierto, Paolo A, Kirkwood, John M
Publicado 2008

Combination therapy: the next opportunity and challenge of medicine

por Ascierto, Paolo A, Marincola, Francesco M
Publicado 2011

What have we learned from cancer immunotherapy in the last 3 years?

por Ascierto, Paolo A, Marincola, Francesco M
Publicado 2014

2015: The Year of Anti-PD-1/PD-L1s Against Melanoma and Beyond

por Ascierto, Paolo A., Marincola, Francesco M.
Publicado 2015

Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?

por Ascierto, Paolo A., McArthur, Grant A.
Publicado 2017

What is changing in the adjuvant treatment of melanoma?

por Ascierto, Paolo A., Palmieri, Giuseppe, Gogas, Helen
Publicado 2017

Melanoma: A model for testing new agents in combination therapies

por Ascierto, Paolo A, Streicher, Howard Z, Sznol, Mario
Publicado 2010

Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application

por Ascierto, Paolo A, Marincola, Francesco M, Ribas, Antoni
Publicado 2011

Therapeutic Advancements Across Clinical Stages in Melanoma, With a Focus on Targeted Immunotherapy

por Trojaniello, Claudia, Luke, Jason J., Ascierto, Paolo A.
Publicado 2021

What’s new in melanoma? Combination!

por Ascierto, Paolo A, Marincola, Francesco M, Atkins, Michael B
Publicado 2015

Melanoma: From Research to Treatment

por Ascierto, Paolo A., Kirkwood, John M., Marincola, Francesco M., Palmieri, Giuseppe
Publicado 2011

No time to die: the consensus immunoscore for predicting survival and response to chemotherapy of locally advanced colon cancer patients in a multicenter international study

por Ascierto, Paolo A., Marincola, Francesco M., Fox, Bernard A., Galon, Jérôme
Publicado 2020

The Role of Optical Radiations in Skin Cancer

por Ayala, Fabrizio, Palla, Marco, Di Trolio, Rossella, Mozzillo, Nicola, Ascierto, Paolo A.
Publicado 2013

Systematic review of the use of granulocyte–macrophage colony-stimulating factor in patients with advanced melanoma

por Hoeller, Christoph, Michielin, Olivier, Ascierto, Paolo A., Szabo, Zsolt, Blank, Christian U.
Publicado 2016

New‐generation anticancer drugs and medication‐related osteonecrosis of the jaw (MRONJ): Late onset 3 years after ipilimumab endovenous administration with a possible role of targe...

por Guida, Agostino, Perri, Francesco, Ionna, Franco, Ascierto, Paolo A., Grimaldi, Antonio M.
Publicado 2020

Overall survival of patients with chemotherapy-naive advanced melanoma treated with ipilimumab 3 mg/kg in clinical trials

por Dummer, Reinhard, Schadendorf, Dirk, Ascierto, Paolo A, Larkin, James, Lebbé, Celeste, Hauschild, Axel
Publicado 2014

Genetic instability and increased mutational load: which diagnostic tool best direct patients with cancer to immunotherapy?

por Palmieri, Giuseppe, Colombino, Maria, Cossu, Antonio, Marchetti, Antonio, Botti, Gerardo, Ascierto, Paolo A.
Publicado 2017

Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical use

por Ascierto, Paolo A, Simeone, Ester, Giannarelli, Diana, Grimaldi, Antonio M, Romano, Anna, Mozzillo, Nicola
Publicado 2012